Laddar...
Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation
Programmed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) inhibition has revolutionized the treatment paradigm of urothelial carcinoma (UC). Several PD-L1 assays are conducted to formulate appropriate treatment decisions for PD-1/PD-L1 target therapy in UC. However, each assay has its o...
Sparad:
| I publikationen: | J Pathol Transl Med |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8141973/ https://ncbi.nlm.nih.gov/pubmed/33823566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4132/jptm.2021.02.22 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|